Literature DB >> 21329773

The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions.

Fredrik Agholme1, Hanna Isaksson, Stuart Kuhstoss, Per Aspenberg.   

Abstract

The secreted protein Dickkopf-1 (Dkk1) is an antagonist of canonical Wnt signaling, expressed during fracture healing. It is unclear how it is involved in the mechanical control of bone maintenance. We investigated the response to administration of a Dkk1 neutralizing antibody (Dkk1-ab) in metaphyseal bone under different loading conditions, with or without trauma. In this three part experiment, 120 rats had a screw or bone chamber inserted either unilaterally or bilaterally in the proximal tibia. Mechanical (pull-out) testing, μCT and histology were used for evaluation. The animals were injected with either 10mg/kg Dkk1-ab or saline every 14days for 14, 28, or 42days. Antibody treatment increased bone formation around the screws and improved their fixation. After 28days, the pull-out force was increased by over 100%. In cancellous bone, the bone volume fraction was increased by 50%. In some animals, one hind limb was paralyzed with Botulinum toxin A (Botox) to create a mechanically unloaded environment. This did not increase the response to antibody treatment with regard to screw fixation, but in cancellous bone, the bone volume fraction increased by 233%. Thus, the response in unloaded, untraumatized bone was proportionally larger, suggesting that Dkk1 may be up-regulated in unloaded bone. There was also an increase in thickness of the metaphyseal cortex. In bone chambers, the antibody treatment increased the bone volume fraction. The results suggest that antibodies blocking Dkk1 might be used to stimulate bone formation especially during implant fixation, fracture repair, or bone disuse. It also seems that Dkk1 is up-regulated both after metaphyseal trauma and after unloading, and that Dkk1 is involved in mechano-transduction.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21329773     DOI: 10.1016/j.bone.2011.02.008

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  22 in total

Review 1.  Periosteum: biology and applications in craniofacial bone regeneration.

Authors:  Z Lin; A Fateh; D M Salem; G Intini
Journal:  J Dent Res       Date:  2013-10-02       Impact factor: 6.116

2.  Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling.

Authors:  Hongting Jin; Baoli Wang; Jia Li; Wanqing Xie; Qiang Mao; Shan Li; Fuqiang Dong; Yan Sun; Hua-Zhu Ke; Philip Babij; Peijian Tong; Di Chen
Journal:  Bone       Date:  2014-09-28       Impact factor: 4.398

3.  Wnt signaling in bone formation and its therapeutic potential for bone diseases.

Authors:  Jeong Hwan Kim; Xing Liu; Jinhua Wang; Xiang Chen; Hongyu Zhang; Stephanie H Kim; Jing Cui; Ruidong Li; Wenwen Zhang; Yuhan Kong; Jiye Zhang; Wei Shui; Joseph Lamplot; Mary Rose Rogers; Chen Zhao; Ning Wang; Prashant Rajan; Justin Tomal; Joseph Statz; Ningning Wu; Hue H Luu; Rex C Haydon; Tong-Chuan He
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-02       Impact factor: 5.346

4.  Sclerostin: a candidate biomarker of SCI-induced osteoporosis.

Authors:  L R Morse; S Sudhakar; A A Lazzari; C Tun; E Garshick; R Zafonte; R A Battaglino
Journal:  Osteoporos Int       Date:  2012-07-17       Impact factor: 4.507

Review 5.  [Overview of animal researches about the effects of systemic drugs on implant osseointegration].

Authors:  Ya-Nan Wang; Ting-Ting Jia; Xin Xu; Dong-Jiao Zhang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-04-01

6.  LRP5 and bone mass regulation: Where are we now?

Authors:  Mark L Johnson
Journal:  Bonekey Rep       Date:  2012-01-10

Review 7.  WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Authors:  Roland Baron; Michaela Kneissel
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

Review 8.  [Mechanobiology and bone metabolism: Clinical relevance for fracture treatment].

Authors:  M Haffner-Luntzer; A Liedert; A Ignatius
Journal:  Unfallchirurg       Date:  2015-12       Impact factor: 1.000

Review 9.  Pharmacologic augmentation of implant fixation in osteopenic bone.

Authors:  R D Ross; J L Hamilton; B M Wilson; D R Sumner; A S Virdi
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

10.  In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma.

Authors:  Samantha Pozzi; Mariateresa Fulciniti; Hua Yan; Sonia Vallet; Homare Eda; Kishan Patel; Loredana Santo; Diana Cirstea; Teru Hideshima; Linda Schirtzinge; Stuart Kuhstoss; Kenneth C Anderson; Nikhil Munshi; David Scadden; Henry M Kronenberg; Noopur Raje
Journal:  Bone       Date:  2013-01-17       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.